As evidence of this, a key regulator of lipid homeostasis, SREBPs (Sterol Regulatory Element-Binding Proteins), and a crucial sensor for nutrient signaling, the mammalian target of rapamycin (mTOR), have been reported to influence lipogenesis to drive prostate cancer growth and progression [7–9]. The gene discussed is MTOR; the disease is prostate cancer.